APR 15, 2020 1:01 PM PDT

Why More Men than Women Die from COVID-19

WRITTEN BY: Annie Lennon

As of April 9th, over 60% of deaths from COVID-19 in New York state were men. Meanwhile, as of April 6, 82% of patients admitted to the ICU in Lombardy, northern Italy, were men. Why? Although a concrete answer to this question still doesn’t exist, several theories may go some way to explain why.

One argument is that women tend to have stronger immune responses than men. Researchers believe that this may partially be because women have two X chromosomes- the chromosome that contains most of the genes related to the immune system. This may thus mean that women have a wider diversity of immune responses and begin to fight off infections sooner, when viral loads are more manageable. 

Another factor may be linked to the fact that women have higher levels of estrogen than men. Just like with COVID-19, more men than women seemed to have died from the virus behind SARS during the outbreak in 2003. To understand why this may be, researchers conducted a study in which they found that male mice tended to be more susceptible to the coronavirus behind SARS than female mice. However, when they diabled the normal function of estrogen in female mice, they found that they were also more likely to get ill. 

Behavioral factors may also be at play. For example, smoking is a known risk factor towards developing severe symptoms from COVID-19. Just about everywhere in the world, men smoke more than women. In China for example, while 54% of men smoke tobacco, just 2.6% of Chinese women do. Although the difference may not be as stark as in other countries such as the US and Spain, the disparity still does exist and so may also explain some of the difference in mortality rate. 

Until more data is known on how COVID-19 affects men and women differently, as well as more detailed mortality statistics from different countries, it will be difficult to draw any conclusions on why the virus kills off more men than women. Once this data is known however, researchers hope that it may be used to help develop different treatments and vaccines for individual patients according to their needs. 


Sources: Vox, Journal of Immunology

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
MAR 19, 2020
Infographics
MAR 19, 2020
All You Need to Know About Coronavirus (CoVID-19)
A new coronavirus, first identified in China in December 2019, has caused an outbreak of respiratory illness that was re ...
MAR 16, 2020
Drug Discovery & Development
MAR 16, 2020
Critical Interleukin Leads to Drug Discovery
The immune molecule interleukin-2 (IL-2) is a growth factor that stimulates the immune system to produce T-cells. Their ...
APR 21, 2020
Clinical & Molecular DX
APR 21, 2020
New Diagnostic FET-based Biosensor Enables Rapid Detection of SARS-CoV-2
The coronavirus disease 2019 (COVID-19) pandemic continues to be at the forefront of the World’s attention. COVID- ...
APR 21, 2020
Health & Medicine
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
Fecal Transplant Helps Fight off Antibiotic Resistance
Fecal transplants work by transporting fecal matter from healthy donors to those who are less healthy. Now, a study has ...
MAY 26, 2020
Drug Discovery & Development
MAY 26, 2020
Everyone Can Produce Antibodies Against COVID-19
Researchers at Rockefeller University in New York have found that most people exposed to COVID-19, and who experience sy ...
Loading Comments...